CD14 and rheumatoid arthritis: In the same 12 patients with RA described above who were treated with MTX alone, the proportions of HLA-DR+CD14+ monocytes and CD69+CD14+ monocytes among all monocytes did not change (Additional file 1: Table S5), which was different from the results for TCZ.